The primary purpose of the study is to investigate the use of VRI to guide the selection of patients for lung surgery. Perfusion scintigraphy is the current method to assess the fractional contribution of lung function of the remaining lung. The hypothesis is that VRI can determine quantitative postoperative lung function equally accurately as a quantitative perfusion scan.
Primarily, VRI will be compared to perfusion (Q) scan by predicted post-operative (ppo) FEV1 and DLCO as predicted by VRI versus as predicted by Q scan. Secondary, the ppo as predicted by each test will be compared with the actual FEV1 and DLCO at 3 months post-operative; If these two methods provide similar results, VRI will be deemed an acceptable alternative to Q scan for determining patient selection for lung resection. Finally, the patient outcomes (30 day mortality and pulmonary complications) for those patients falling within guideline parameters using the VRI measurement will be analyzed to see if using VRI in clinical practice would indeed allow prediction of satisfactory results (similar to literature benchmarks).
Study Type
OBSERVATIONAL
Enrollment
200
The study is designed in a way that will not alter the surgeon's decision based on routine assessment of candidates for resection (lobectomy or greater). Namely, the VRI data will be gathered prospectively; however, the analyses using VRI data will be performed retrospectively.
Yale University School of Medicine
New Haven, Connecticut, United States
Emory University
Atlanta, Georgia, United States
Boston Medical Center, Boston University
Boston, Massachusetts, United States
Mt. Sinai School of Medicine
New York, New York, United States
Comparison of ppo FEV1 and ppo DLCO as predicted by VRI with the values as predicted by Q scan
Time frame: Prior to surgery
Comparison of ppo as predicted by each test with the actual FEV1 and DLCO at 3 months post-operative
Time frame: 3 months after surgery
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
New York-Presbyterian Hospital/Columbia University Medical Center
New York, New York, United States
The University of Texas MD Anderson Cancer Center
Houston, Texas, United States